News

At the EOSC Symposium and the Nextflow Summit, GHGA members strengthened collaborations, shared expertise, and engaged with international experts on advancing FAIR principles and scalable bioinformatics solutions.

Participating in several conferences in September, GHGA members networked closely with various communities ranging from bioinformatic, research data infrastructure, to ethics scholars.

In a recent publication, the FAIR Workflows Working Group of the Workflow Community Initiative offers recommendations to assist researchers and developers in creating workflows that are easy to share, reusable, and adoptable across disciplines.

A recent publication with GHGA contribution introduces nf-core/sarek 3, a comprehensive variant calling and annotation pipeline designed for both germline and somatic samples.

Benchmarking small pathogenic and structural variants can be challenging. Utilizing cutting-edge SeraSeq, GHGA partners with the NGS-CN to start a new initiative to benchmark NGS pipelines.

GHGA joined the de.NBI/ELIXIR-Germany Spatial Hackathon ‘SpaceHack2.0’, advancing community-driven benchmarking.

A recent publication, spearheaded by the Next Generation Sequencing Competence Network (NGS-CN) and GHGA, introduces NCBench, a platform for continuous benchmarking of genomic variant calling workflows.

Participating actively in two conferences in September, CoRDI and GCB, GHGA members networked closely with the research data infrastructure and bioinformatics communities.

The GHGA workflow workstream was involved in the release of bioinformatic workflows (sarek 3.0, nanoseq 3.0, and DROP 1.2), collaborating with the nf-core community and the Gagneur lab.

First GHGA webinar was successfully held - it included a Beginners Guide to DNA and Sequencing and an introduction to bioinformatic workflows.

End of April, the GHGA development team participated in the "ELIXIR Compute Platform 2022 Face-to-Face Meeting" in Berlin and introduced the GHGA mission and architecture strategy to the Compute Platform members.

A new study introduces a workflow with the clinical implementation of RNA sequencing in conjunction with DNA sequencing to diagnose patients with rare genetic disorders.